INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2018

A Khorasan wheat replacement diet reduced liver enzymes and inflammatory markers in NAFLD.

Forty adults with mild to moderate nonalcoholic fatty liver disease were randomized to consume ancient KAMUT khorasan or modern wheat products for 3 months. Compared with baseline, the khorasan group had significant reductions in alanine aminotransferase by 12%, aspartate aminotransferase by 14%, alkaline phosphatase by 8%, and cholesterol by 6% (all p < 0.05). Proinflammatory cytokines decreased significantly only with khorasan, while steatosis grading and reactive oxygen species improved in both study groups.

Study type
Randomized controlled trial
Who was studied
40 adults with nonalcoholic fatty liver disease
What was measured
Liver enzymes, inflammatory markers, and liver steatosis

THE PAPER

A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial.

Dinu M, Whittaker A, Pagliai G, Giangrandi I, Colombini B, Gori AM, Fiorillo C, Becatti M, Casini A, Benedettelli S, Sofi F. J Am Coll Nutr, 2018.

PubMed 29652567 ↗DOI 10.1080/07315724.2018.1445047 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.